Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01f7d3d9295f6bf513bd55ec626cf461 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
filingDate |
2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c16f542ec03631a301baf41688c523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9d0bac9ec41cc5e270d54356852c90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89d63cd2abe3e3b94a31577ee3ee5aff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e21dc2299ce4b9715ae7d3b3cd6496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff018342238553e773e0619d87b855bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de7033816e65adcc6e1ca78c95c483c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef452ee56d75f4bd7a2e0b42de479007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_329877d72dc780ae86ef1fcc783b9599 |
publicationDate |
2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7196177-B2 |
titleOfInvention |
Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
abstract |
An antibody variable region of a monoclonal antibody specifically binding to human tumor necrosis factor-α contains at least one of a heavy chain variable region and a light chain variable region having specific complementarity determining regions therein. A nucleic acid molecule encoding the same, a recombinant vector containing the nucleic acid molecule, and a cell transformed with the recombinant vector are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008008703-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011182906-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7645450-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8354108-B2 |
priorityDate |
2003-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |